Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 2 |
2018 | 1 |
2023 | 0 |
Search Results
3 results
Results by year
Page 1
Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma.
J Nucl Med. 2017 Sep;58(9):1414-1420. doi: 10.2967/jnumed.116.185280. Epub 2017 Mar 9.
J Nucl Med. 2017.
PMID: 28280225
Free article.
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.
Mesguich C, Cazeau AL, Bouabdallah K, Soubeyran P, Guyot M, Milpied N, Bordenave L, Hindié E.
Mesguich C, et al.
Br J Haematol. 2016 Nov;175(4):652-660. doi: 10.1111/bjh.14292. Epub 2016 Aug 19.
Br J Haematol. 2016.
PMID: 27539369
Free article.
Item in Clipboard
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee.
Mesguich C, Cazeau AL, Bouabdallah K, Hindié E.
Mesguich C, et al.
Br J Haematol. 2018 Apr;181(1):124-125. doi: 10.1111/bjh.14494. Epub 2017 Jan 20.
Br J Haematol. 2018.
PMID: 28106255
Free article.
No abstract available.
Item in Clipboard
Cite
Cite